Daratumumab combination is recommended for use within the NHS in England and Wales for treating adults with newly diagnosed multiple myeloma where a stem cell transplant is unsuitableEligible patients throughout England and Wales can now access alternative combination treatment option which has been shown to delay d.
A treatment for acute migraine has been recommended for use by clinicians in the NHS in England for the first time, according to the National Institute for Health and Care Excellence (NICE).